Literature DB >> 33971883

Metabolic syndrome and its components reduce coronary collateralization in chronic total occlusion: An observational study.

Tong Liu1, Zheng Wu1, Jinghua Liu2, Yun Lv1, Wenzheng Li1.   

Abstract

BACKGROUND: Metabolic syndrome (MetS) is an independent risk factor for the incidence of cardiovascular diseases. We investigated whether or to what extent MetS and its components was associated with coronary collateralization (CC) in chronic total occlusion (CTO).
METHODS: This study involved 1653 inpatients with CTO. Data on demographic and clinical characteristics were collected by cardiovascular doctors. The CC condition was defined by the Rentrop scoring system. Subgroup analysis, mixed model regression analysis, scoring systems and receiver operating characteristic (ROC) curve analysis were performed.
RESULTS: Overall, 1653 inpatients were assigned to the poor CC group (n = 355) and good CC group (n = 1298) with or without MetS. Compared to the good CCs, the incidence of MetS was higher among the poor CCs for all patients. Poor collateralization was present in 7.6%, 14.2%, 19.3%, 18.2%, 35.6% and 51.1% of the six groups who met the diagnostic criteria of MetS 0, 1, 2, 3, 4 and 5 times, respectively. For multivariable logistic regression, quartiles of BMI remained the risk factors for CC growth in all subgroups (adjusted OR = 1.755, 95% CI 1.510-2.038, P < 0.001 all patients; adjusted OR = 1.897, 95% CI 1.458-2.467, P < 0.001 non-MetS; and adjusted OR = 1.814, 95% CI 1.482-2.220, P < 0.001 MetS). After adjustment for potential confounding factors, MetS was an independent risk factor for CC growth in several models. Assigning a score of one for each component, the AUCs were 0.629 (95% CI 0.595-0.662) in all patients, 0.656 (95% CI 0.614-0.699) in MetS patients and 0.569 (95% CI 0.517-0.621) in non-MetS patients by receiver operating characteristic analysis.
CONCLUSIONS: MetS, especially body mass index, confers a greater risk of CC formation in CTO. The value of scoring systems should be explored further for CTO.

Entities:  

Keywords:  Chronic total occlusion; Components; Coronary collateralization; Metabolic syndrome; Scoring system

Year:  2021        PMID: 33971883     DOI: 10.1186/s12933-021-01297-4

Source DB:  PubMed          Journal:  Cardiovasc Diabetol        ISSN: 1475-2840            Impact factor:   9.951


  42 in total

1.  Association of blood pressure and coronary collateralization in type 2 diabetic and nondiabetic patients with stable angina and chronic total occlusion.

Authors:  Ying Shen; Feng Hua Ding; Feng Wu; Lin Lu; Rui Yan Zhang; Qi Zhang; Zong Gui Wu; Wei Feng Shen
Journal:  J Hypertens       Date:  2015-03       Impact factor: 4.844

Review 2.  The dynamics of the coronary collateral circulation.

Authors:  Marco Zimarino; Mariangela D'Andreamatteo; Ron Waksman; Stephen E Epstein; Raffaele De Caterina
Journal:  Nat Rev Cardiol       Date:  2014-01-07       Impact factor: 32.419

3.  Elevated 20-HETE impairs coronary collateral growth in metabolic syndrome via endothelial dysfunction.

Authors:  Gregory Joseph; Amanda Soler; Rebecca Hutcheson; Ian Hunter; Chastity Bradford; Brenda Hutcheson; Katherine H Gotlinger; Houli Jiang; John R Falck; Spencer Proctor; Michal Laniado Schwartzman; Petra Rocic
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-12-23       Impact factor: 4.733

4.  Predictors, treatment, and long-term outcomes of coronary perforation during retrograde percutaneous coronary intervention via epicardial collaterals for recanalization of chronic coronary total occlusion.

Authors:  Kaize Wu; Zehan Huang; Zhian Zhong; Hongtao Liao; Yi Zhou; Bingzheng Luo; Bin Zhang
Journal:  Catheter Cardiovasc Interv       Date:  2019-01-28       Impact factor: 2.692

5.  Eff ects of metabolic syndrome on onset age and long-term outcomes in patients with acute coronary syndrome.

Authors:  Jing-Jing Xu; Ying Song; Ping Jiang; Lin Jiang; Xue-Yan Zhao; Zhan Gao; Jian-Xin Li; Shu-Bin Qiao; Run-Lin Gao; Yue-Jin Yang; Yin Zhang; Bo Xu; Jin-Qing Yuan
Journal:  World J Emerg Med       Date:  2021

Review 6.  Recruitment and maturation of the coronary collateral circulation: Current understanding and perspectives in arteriogenesis.

Authors:  Usaid K Allahwala; Levon M Khachigian; Daniel Nour; Anisyah Ridiandres; Muntasir Billah; Michael Ward; James Weaver; Ravinay Bhindi
Journal:  Microvasc Res       Date:  2020-08-13       Impact factor: 3.514

7.  The Metabolic Syndrome Does Not Affect Development of Collateral Circulation in the Poststenotic Swine Kidney.

Authors:  Xin Zhang; Seo Rin Kim; Christopher M Ferguson; Behzad Ebrahimi; Ahmad F Hedayat; Amir Lerman; Lilach O Lerman
Journal:  Am J Hypertens       Date:  2018-11-13       Impact factor: 2.689

8.  Decreased inspired oxygen stimulates de novo formation of coronary collaterals in adult heart.

Authors:  Amir Aghajanian; Hua Zhang; Brian K Buckley; Erika S Wittchen; Willa Y Ma; James E Faber
Journal:  J Mol Cell Cardiol       Date:  2020-10-08       Impact factor: 5.000

Review 9.  Reduced coronary collateralization in type 2 diabetic patients with chronic total occlusion.

Authors:  Ying Shen; Feng Hua Ding; Yang Dai; Xiao Qun Wang; Rui Yan Zhang; Lin Lu; Wei Feng Shen
Journal:  Cardiovasc Diabetol       Date:  2018-02-08       Impact factor: 9.951

10.  Metabolic Syndrome and Coronary Artery Disease Risk: A Meta-Analysis of Observational Studies.

Authors:  Amal F Alshammary; Khalid Khalaf Alharbi; Naif Jameel Alshehri; Vishal Vennu; Imran Ali Khan
Journal:  Int J Environ Res Public Health       Date:  2021-02-11       Impact factor: 3.390

View more
  4 in total

1.  Increased estimated remnant-like particle cholesterol is associated with impaired coronary collateralization in patients with coronary chronic total occlusions.

Authors:  Ang Gao; Jinxing Liu; Yan Liu; Chengping Hu; Yong Zhu; Yujie Zhou; Hongya Han; Yingxin Zhao
Journal:  Diabetol Metab Syndr       Date:  2022-04-21       Impact factor: 3.320

2.  Association between the triglyceride glucose index and coronary collateralization in coronary artery disease patients with chronic total occlusion lesions.

Authors:  Ang Gao; Jinxing Liu; Chengping Hu; Yan Liu; Yong Zhu; Hongya Han; Yujie Zhou; Yingxin Zhao
Journal:  Lipids Health Dis       Date:  2021-10-25       Impact factor: 3.876

3.  Serum CTRP9 Reflects Coronary Collateralization in Nondiabetic Patients with Obstructive Coronary Artery Disease.

Authors:  Ang Gao; Jinxing Liu; Yan Liu; Chengping Hu; Yong Zhu; Yujie Zhou; Hongya Han; Yingxin Zhao
Journal:  Biomed Res Int       Date:  2022-03-10       Impact factor: 3.411

Review 4.  Diabetic dyslipidemia impairs coronary collateral formation: An update.

Authors:  Ying Shen; Xiao Qun Wang; Yang Dai; Yi Xuan Wang; Rui Yan Zhang; Lin Lu; Feng Hua Ding; Wei Feng Shen
Journal:  Front Cardiovasc Med       Date:  2022-08-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.